Go Pro

Tilray Brands (TLRY) Competitors

Tilray Brands logo
C$6.23 -0.01 (-0.16%)
As of 09/3/2026 04:00 PM Eastern

TLRY vs. BHC, CRON, MJN, CARA, and DHT.UN

Should you buy Tilray Brands stock or one of its competitors? Tilray Brands's main competitors and comparable companies include Bausch Health Companies (BHC), Cronos Group (CRON), Cronos Group (MJN), Cara Operations (CARA), and DRI Healthcare Trust (DHT.UN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Tilray Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

In the previous week, Bausch Health Companies had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for Bausch Health Companies and 0 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.71 beat Bausch Health Companies' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Bausch Health Companies Neutral
Tilray Brands Positive

Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 113.48%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.85B0.32-C$125.65M-C$2.94N/A
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A

10.4% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.2% of Tilray Brands shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bausch Health Companies has a net margin of -12.02% compared to Tilray Brands' net margin of -15.22%. Bausch Health Companies' return on equity of 87.57% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-12.02% 87.57% 4.16%
Tilray Brands -15.22%-8.85%-1.41%

Bausch Health Companies has a beta of 0.959729, indicating that its share price is 4% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.215277, indicating that its share price is 222% more volatile than the broader market.

Summary

Bausch Health Companies beats Tilray Brands on 9 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

4.4% of Cronos Group shares are held by institutional investors. Comparatively, 4.2% of Tilray Brands shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cronos Group has a net margin of 38.95% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 6.46% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group38.95% 6.46% -3.73%
Tilray Brands -15.22%-8.85%-1.41%

Cronos Group has a beta of 1.13355, suggesting that its share price is 13% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.215277, suggesting that its share price is 222% more volatile than the broader market.

Cronos Group currently has a consensus price target of C$4.92, suggesting a potential upside of 10.24%. Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 113.48%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Tilray Brands' average media sentiment score of 0.71 beat Cronos Group's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
Tilray Brands Positive

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$179.09M9.17-C$32.78MC$0.1923.47
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A

Summary

Cronos Group beats Tilray Brands on 10 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (CVE:MJN) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Cronos Group has higher earnings, but lower revenue than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupN/AN/AN/AN/AN/A
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A

Cronos Group has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos GroupN/A N/A N/A
Tilray Brands -15.22%-8.85%-1.41%

Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 113.48%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Cronos Group had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.71 beat Cronos Group's score of 0.51 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Positive
Tilray Brands Positive

4.2% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Tilray Brands beats Cronos Group on 6 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Cara Operations (TSE:CARA) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Cara Operations has higher earnings, but lower revenue than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cara OperationsN/AN/AN/AN/AN/A
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Cara OperationsN/A N/A N/A
Tilray Brands -15.22%-8.85%-1.41%

4.2% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Tilray Brands' average media sentiment score of 0.71 beat Cara Operations' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Cara Operations Neutral
Tilray Brands Positive

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 113.48%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Tilray Brands beats Cara Operations on 6 of the 9 factors compared between the two stocks.

How does Tilray Brands compare to DRI Healthcare Trust?

Tilray Brands (TSE:TLRY) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -15.22%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-15.22% -8.85% -1.41%
DRI Healthcare Trust 5.02%2.06%4.22%

Tilray Brands has a beta of 3.215277, suggesting that its share price is 222% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.365327, suggesting that its share price is 63% less volatile than the broader market.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Tilray Brands. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Tilray Brands. DRI Healthcare Trust's average media sentiment score of 1.49 beat Tilray Brands' score of 0.71 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Tilray Brands Positive
DRI Healthcare Trust Positive

DRI Healthcare Trust has lower revenue, but higher earnings than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A
DRI Healthcare TrustC$172.34M5.57C$9.73M-C$0.80N/A

4.2% of Tilray Brands shares are owned by institutional investors. Comparatively, 0.8% of DRI Healthcare Trust shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 113.48%. DRI Healthcare Trust has a consensus price target of C$25.20, suggesting a potential upside of 44.33%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

Summary

DRI Healthcare Trust beats Tilray Brands on 11 of the 17 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$864.10MC$12.25BC$7.26BC$12.57B
Dividend YieldN/A2.59%2.53%6.25%
P/E Ratio-5.72787.27273.2939.47
Price / Sales0.94753.79613.459.82
Price / Cash5.9594.8077.8282.29
Price / Book0.4512.3312.894.71
Net Income-C$183.24MC$2.82BC$3.47BC$299.09M
7 Day Performance-2.20%2.59%0.60%-0.31%
1 Month Performance-4.59%6.95%5.73%3.12%
1 Year Performance-60.57%9.45%25.35%28.73%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
1.4213 of 5 stars
C$6.23
-0.2%
C$13.30
+113.5%
-61.8%C$864.10MC$915.45MN/A2,650
BHC
Bausch Health Companies
0.328 of 5 stars
C$9.03
-3.0%
N/A-8.1%C$3.38BC$10.85BN/A19,900
CRON
Cronos Group
1.8139 of 5 stars
C$4.95
+2.1%
C$4.92
-0.7%
+28.2%C$1.82BC$179.09M26.05450
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/AN/A7,600
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80

Related Companies and Tools


This page (TSE:TLRY) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners